PROFUSA, Inc.
PFSA Healthcare Medical Devices
PROFUSA, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $100,000.00. In the quarter to June 2026, EPS grew 98.3%, free cash flow fell 359.3% and total debt fell 89.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow PFSA
PROFUSA, Inc. (PFSA) Altman Z-score
PROFUSA, Inc.'s Altman Z-score for fiscal 2024 is −83.94, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2024 | −83.94 | — |
How fiscal 2024’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | (18.51) | — | −22.21 | |
| Retained earnings / total assets | (40.66) | — | −56.93 | |
| EBIT / total assets | (1.46) | — | −4.83 | |
| Market value of equity / total liabilities | 0.00 | — | 0.00 | |
| Sales / total assets | 0.03 | — | 0.03 | |
| Altman Z-score | Distress zone | −83.94 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −264.83 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| DHAI DIH Holding US, Inc. compare | −1.8× |
| DYNTQ Dynatronics Corporation compare | −2.3× |
| FEED ENvue Medical, Inc. compare | −4.7× |
| SSKN Strata Skin Sciences, Inc. compare | −11.5× |
| AFIB Acutus Medical, Inc. compare | −28.5× |
| MOTS Motus GI Holdings, Inc. compare | −34.7× |
| THMO ThermoGenesis Holdings, Inc. compare | −37.8× |
| NUWE Nuwellis, Inc. compare | −76.4× |
| PFSA PROFUSA, Inc. | −83.9× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets